SPONSOR
University of Iowa
Total Trials
3
Recruiting
3
Phases
Phase 2, EARLY_Phase 1
Conditions studied: Neuroendocrine TumorsNeuroendocrine Tumor Grade 1Neuroendocrine Tumor Grade 2DeliriumPain, BackSpinal FusionThoracolumbar Interfascial Plane BlockExudative Macular DegenerationWet Age-related Macular Degeneration
University of Iowa is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Neuroendocrine Tumors, Neuroendocrine Tumor Grade 1, Neuroendocrine Tumor Grade 2, Delirium.
The trial portfolio spans Phase 2, EARLY_Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University of Iowa
How many clinical trials has University of Iowa sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by University of Iowa, of which 3 are actively recruiting participants. These trials cover conditions including Neuroendocrine Tumors, Neuroendocrine Tumor Grade 1, Neuroendocrine Tumor Grade 2. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University of Iowa research focus on?
University of Iowa clinical trials span Neuroendocrine Tumors, Neuroendocrine Tumor Grade 1, Neuroendocrine Tumor Grade 2, Delirium, Pain, Back, and additional conditions. The research pipeline includes Phase 2, EARLY_Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University of Iowa clinical trial?
To participate in a University of Iowa trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University of Iowa trials with current recruitment status updated daily.
Clinical Trials by University of Iowa
NCT06395402 Phase 2
Recruiting
177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry
Neuroendocrine Tumors
NCT05461092 EARLY_Phase 1
Recruiting
Regional Nerve Blocks to Improve Analgesia and Recovery in Older Adults Undergoing Spinal Fusion
Delirium
NCT04504123 Phase 2
Recruiting
MMP-9 Inhibition for Recalcitrant Wet AMD
Exudative Macular Degeneration
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology